Spire Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
IA
JWS
TWM
OPAM
QCIG
CWP
FFA
FEG
TCOO
Spire Wealth Management's FBT Position: Q2 2026 in Review
Spire Wealth Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 18% in Q2 2026, buying an estimated $1.94K and bringing the position to 59 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.
Spire Wealth Management first reported a position in FBT in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.46M in Q1 2021. 64 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Spire Wealth Management held 59 shares of First Trust NYSE Arca Biotechnology Index Fund worth $14.6K as of Q2 2026.
- Spire Wealth Management bought 9 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.94K.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1537 holding.
- Spire Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2021 and has held it in 19 quarters since.
- Spire Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.46M in Q1 2021.
- 64 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.